Ann Shinnar
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ann Shinnar.
Peptides | 2003
Thomas Uzzell; Ethan D. Stolzenberg; Ann Shinnar; Michael Zasloff
Three potent broad-spectrum antimicrobial peptides (HFIAP-1, -2, and -3) isolated from intestinal tissues of Myxine glutinosa (Atlantic hagfish) are identified as ancient members of the cathelicidin family of antimicrobial peptides, hitherto known only from mammals. In situ hybridization reveals that HFIAPs are produced in nests of myeloid cells within the loose connective tissue of the gut wall, a tissue reminiscent of both gut-associated lymphoid tissue (GALT) and vertebrate spleen. We suggest that this tissue organization provides local defense of the hagfish gastrointestinal tract via innate immunity and possibly served as the architectural plan upon which the adaptive immune system evolved.
Bioorganic Chemistry | 2003
Ann Shinnar; Kathryn L. Butler; Hyon Ju Park
Cathelicidins are a gene family of antimicrobial peptides produced as inactive precursors. Signal peptidase removes the N-terminal signal sequence, while peptidylglycine alpha-amidating monooxygenase often amidates and cleaves the C-terminal region. Removal of the cathelin domain liberates the active antimicrobial peptide. For mammalian sequences, this cleavage usually occurs through the action of elastase, but other tissue-specific processing enzymes may also operate. Once released, these bioactive peptides are susceptible to proteolytic degradation. We propose that some mature cathelicidins are naturally resistant to proteases due to their unusual primary structures. Among mammalian cathelicidins, proline-rich sequences should resist attack by serine proteases because proline prevents cleavage of the scissile bond. In hagfish cathelicidins, the unusual amino acid bromotryptophan may make the active peptides less susceptible to proteolysis for steric reasons. Such protease resistance could extend the pharmacokinetic lifetimes of cathelicidins in vivo, sustaining antimicrobial activity.
Archive | 1996
Michael Zasloff; Ann Shinnar; William A. Kinney; Steven M. Jones
Archive | 1995
Michael Zasloff; Ann Shinnar; William A. Kinney; Meena Rao
Archive | 1995
Michael Zasloff; Ann Shinnar; William A. Kinney; Steven Jones
Archive | 1995
Michael Zasloff; Ann Shinnar; William A. Kinney; Meena Rao
Archive | 1995
Michael Zasloff; Ann Shinnar; Meena Rao; William A. Kinney
Archive | 1996
Ann Shinnar; Michael Zasloff; Thomas Uzzell
Archive | 2006
Michael Zasloff; Ann Shinnar; William A. Kinney; Steven M. Jones
Archive | 1996
Mark S. Anderson; Steven M. Jones; William A. Kinney; Michael P. McLane; Meena N. Rao; Ann Shinnar; Jon I. Williams; Michael Zasloff